期刊论文详细信息
Frontiers in Cardiovascular Medicine | |
Impact of cystatin C-derived glomerular filtration rate in patients undergoing transcatheter aortic valve implantation | |
Cardiovascular Medicine | |
Mana Ogawa1  Atsushi Shibata1  Tomohiro Yamaguchi1  Daiju Fukuda1  Yusuke Kure1  Yasuhiro Izumiya1  Asahiro Ito1  Tsukasa Okai1  Toshihiko Shibata2  Yosuke Takahashi2  Hisako Yoshida3  Kazuki Mizutani4  | |
[1]Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan | |
[2]Department of Cardiovascular Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan | |
[3]Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan | |
[4]Division of Cardiology, Department of Medicine, Kindai University Faculty of Medicine, Osaka, Japan | |
关键词: TAVI; aortic stenosis; cystatin c; CKD; creatinine; | |
DOI : 10.3389/fcvm.2023.1035736 | |
received in 2022-09-03, accepted in 2023-03-27, 发布年份 2023 | |
来源: Frontiers | |
【 摘 要 】
BackgroundChronic kidney disease (CKD) impacts prognosis in patients undergoing transcatheter aortic valve implantation (TAVI). While estimated glomerular filtration rate (eGFR) calculated from serum creatinine [eGFR (creatinine)] is affected by body muscle mass which reflects frailty, eGFR calculated from serum cystatin C [eGFR (cystatin C)] is independent of body composition, resulting in better renal function assessment.MethodsThis study included 390 consecutive patients with symptomatic severe aortic stenosis (AS) who underwent TAVI, and measured cystatin C-based eGFR at discharge. Patients were divided into two groups, with or without CKD estimated with eGFR (cystatin C). The primary endpoint of this study was the 3-year all-cause mortality after TAVI.ResultsThe median patient age was 84 years, and 32.8% patients were men. Multivariate Cox regression analysis indicated that eGFR (cystatin C), diabetes mellitus, and liver disease were independently associated with 3-year all-cause mortality. In the receiver-operating characteristic (ROC) curve, the predictive value of eGFR (cystatin C) was significantly higher than that of eGFR (creatinine). Furthermore, Kaplan–Meier estimates revealed that 3-year all-cause mortality was higher in the CKD (cystatin C) group than that in the non-CKD (cystatin C) group with log-rank p = 0.009. In contrast, there was no significant difference between the CKD (creatinine) and non-CKD (creatinine) groups with log-rank p = 0.94.ConclusionseGFR (cystatin C) was associated with 3-year all-cause mortality in patients who underwent TAVI, and it was superior to eGFR (creatinine) as a prognostic biomarker.【 授权许可】
Unknown
© 2023 Kure, Okai, Izumiya, Yoshida, Mizutani, Yamaguchi, Ogawa, Shibata, Ito, Takahashi, Shibata and Fukuda.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202310104858022ZK.pdf | 737KB | download |